Duke LEAP

The Duke LEAP follow-up science survey will close today (March 18th). If you received a survey invitation via email, we encourage you to take 15 - 20 minutes of your time today to complete the survey and ensure your experiences are represented.

The LEAP study launched a new survey today to follow-up with Duke alumni that have previously completed surveys to gain a better understanding of how college experiences shape beliefs and understanding of science and to inform the evaluation of the LEAP summer mini-course. If you received a survey invitation, we would appreciate it if you could take 15 - 20 minutes to complete the survey and contribute to an NIH-funded study that has helped advance science and improve science education. If you did not receive the survey invitation, please send us a private message.

We are excited to announce that the LEAP study received additional support from the National Institutes of Health to continue research to advance our understanding of how people make decisions about whether and how to participate in science.

This research is being conducted by Drs. Linnenbrink-Garcia at Michigan State University (formerly of Duke University), Rochelle Schwartz-Bloom at Duke University, and Tony Perez at Old Dominion University.

We hope everyone had a great time at LEAP Session 2! Be sure to tag yourself in our group photo, and have a great rest of the summer.

LEAP Session 1 was awesome! I hope everyone had a great time! Don't forget to tag yourself in our group photo. :)

North Carolina could soon become one of only two states in the country to protect pharmaceutical companies from almost all lawsuits once a drug is approved by the FDA! Check out the article here: http://www.wral.com/news/state/nccapitol/story/9610327/

What does everyone think? Is this a good idea?

NC House delays votes on protecting drug makers :: WRAL.com The state House postponed its planned vote Wednesday on whether to make the state just the second in the country to protect pharmaceutical companies from almost all lawsuits.